GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Genomic Health, Inc. (GHDX) [hlAlert]

Rating:
Neutral GHDX

Genomic Health, Inc. (GHDX) rated Neutral by GARP Research

Posted on: Tuesday,  Feb 21, 2012  9:25 AM ET by GARP Research

Genomic Health, Inc.
(NASDAQ: GHDX) rated Neutral by GARP Research.

Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. It launched its first test, Oncotype DX, which has been shown to predict the likelihood of breast cancer recurrence and chemotherapy benefit in early stage breast cancer patients. The Oncotype DX assay represents the first diagnostic gene expression test on the market that provides consistent results across multiple independent trials having breast cancer patients, including a large validation study of The New England Journal of Medicine.

We are long term investors and all of our recommendations are driven by a single investment philosophy. Whereas most investment research firms build their coverage around industry sectors or corporate finance interests, we simply focus on finding high-quality stocks that we consider to be attractively priced and have the potential to materially appreciate over a two to three year timeframe. All of our recommendations must meet specific criteria of our defined investment philosophy incorporating elements of growth, quality and control of risk. Importantly, we have a multi-year performance record which we believe validates our methodology and points to the thoroughness of our work.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/21/2012 9:25 AM Hold
None
28.02
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy